Invasive Fungal Infections After Intestine Transplantation: Epidemiology and Outcomes
Mycoses · 2026-05 · 69 (5)
DOI: 10.1111/myc.70180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, online erschienen am 28.04.2026. Verfasst von Mayyadah H Alabdely und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Intestines, Invasive Fungal Infections, Organ Transplantation, Postoperative Complications. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Invasive fungal infections (IFIs) represent a major complication after intestine transplantation, with reported incidence rates between 40% and 49%. These infections are associated with high morbidity and allograft loss. This study evaluates the impact of post‐transplant IFIs on graft outcomes in intestine transplant recipients.
Methods
We conducted a retrospective cohort study of 152 patients who underwent intestine transplantation from 2008 to 2022. The primary outcome was IFI, defined as proven or probable by EORTC/MSGERC criteria. The secondary outcome was a composite of allograft failure or death. Analyses were conducted using multivariable Cox proportional hazards models, with non‐baseline variables incorporated as time‐dependent exposures.
Results
Among 152 intestine transplant recipients, 56 (36.8%) developed post‐transplant IFI. Median time to IFI was 83.5 days (IQR 19.5–444.2), with Candida infections occurring early and non‐ Candida infections occurring later. Candida species accounted for 73% of IFIs, most commonly C. glabrata , C. albicans , and C. parapsilosis , with 29.3% showing fluconazole resistance. Most infections were intra‐abdominal and bloodstream. Redo transplantation (HR 2.44, 95% CI 1.20–4.95; p = 0.014), anastomotic leak (HR 2.23, 95% CI 1.02–4.90; p = 0.045), and augmented immunosuppression (HR 4.73, 95% CI 1.94–11.53; p < 0.001) were independent predictors of Candida IFI. IFI was associated with a markedly increased risk of allograft loss or death (HR 3.67, 95% CI 2.30–5.83; p < 0.001).
Conclusions
Post‐transplant IFIs are common and associated with allograft loss or mortality in intestine transplant recipients. Early recognition and aggressive management of IFIs remain critical to improving transplant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
- Center for Pediatric Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
- Center for Gut Rehabilitation and Transplantation, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
ORCID-Profile: Zachary A Yetmar
Zitieren
APA
Alabdely, M. H., Lum, J., Gonzalez, B. E., Fujiki, M., & Yetmar, Z. A. (2026). Invasive Fungal Infections After Intestine Transplantation: Epidemiology and Outcomes. Mycoses, 69(5). https://doi.org/10.1111/myc.70180
Vancouver
Alabdely MH, Lum J, Gonzalez BE, Fujiki M, Yetmar ZA. Invasive Fungal Infections After Intestine Transplantation: Epidemiology and Outcomes. Mycoses. 2026;69(5). doi:10.1111/myc.70180
BibTeX
@article{Alabdely2026,
author = {Alabdely, Mayyadah H and Lum, Jessica and Gonzalez, Blanca E and Fujiki, Masato and Yetmar, Zachary A},
title = {Invasive Fungal Infections After Intestine Transplantation: Epidemiology and Outcomes},
journal = {Mycoses},
year = {2026},
volume = {69},
number = {5},
doi = {10.1111/myc.70180}
}
EUVIMED